1.Effect of light at night on liver metabolism in miceby untargeted metabolomics
ZHANG Rong ; LIU Chun Hua ; HU Shuang ; LI Peng Xiang ; WEI Shou Gang
Journal of Preventive Medicine 2021;33(2):130-134
Objective:
To observe the changes of liver metabolism in mice exposed to artificial light at night.
Methods:
Healthy male C57BL/6J mice were randomly divided into the light at night group and the control group, with 8 mice in each group. The daily light/dark cycle was 12/12 hours in the control group, and 24/0 hours in the light at night group for 10 consecutive days. The hepatic metabolite profiles of the two groups of mice were detected by high performance liquid chromatography tandem mass spectrometry. The modelling was assessed by combining principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis ( OPLS-DA ) , The changes of metabolites in the two groups were compared through KEGG database.
Results:
Compared with the control group, 9 different metabolites were detected in the light at night group, among which the down-regulated metabolites were glycine-betaine, glutathione, tyrosine, betaine, lysine, hypoxanthine, histidine and methionine, and the up-regulated ones were mannose-6-phosphate. The weight analysis of the metabolic pathways showed that the major influences on liver of light at night group were phenylalanine-tyrosine-tryptophan metabolism, tyrosine metabolism, fructose and mannose metabolism, cysteine and methionine metabolism and histidine metabolism.
Conclusion
The metabolism of various amino acids and sugars in light at night mice is disturbed,and the key differential metabolites are tyrosine, methionine, histidine and mannose-6-phosphate.
2.Experimental study on intestinal bacterial translocation in acute hepatic failure in rats.
Shou-rong LIU ; Guo-qiang LOU ; Wen-bao HUANG
Chinese Journal of Experimental and Clinical Virology 2007;21(2):126-128
OBJECTIVETo investigate if glutamine (Gln) reduces intestinal bacterial translocation in acute hepatic failure (AHF) in rats and its mechanisms.
METHODSAcute hepatic failure model in rat was established by intraperitoneal injection of galatosamine. The rats were randomly divided into 4 groups: the normal control group (A), prevention and treatment group (B), treatment group (C), and model group (D). The rats in groups A and D were fed with normal saline. Two days before intraperitoneal injection, the rats in group B were fed with Gln and those in group C were fed with Gln 24 hours after injection. After 4 days of treatment, the rats were sacrificed and pathological scores of liver were assessed. The percentage of intestinal bacterial transloaction and bacteria in mesenteric lymph nodes (MLN) were measured. The villus height, crypt depth of ileum mucosa were analyzed. The levels of serum diamine oxidase (DAO) were measured.
RESULTSThe liver pathological scores of groups B and C were significantly lower than those of group D. The frequency of the bacteria found in MLN was significantly lower in group B compared with group D. The levels of DAO in blood were significantly lower in groups B and C than that of group D, and the level was significantly lower in group B than in group C. The villus height and crypt depth of the mucosa were significantly greater in group B and group C than in group D, and greater in group B than in group C.
CONCLUSIONThe results of the present study show that Gln can reduce the occurrence of the intestinal bacterial translocation in AHF in rats by improving the function of intestinal barrier.
Animals ; Bacterial Physiological Phenomena ; Bacterial Translocation ; Glutamine ; metabolism ; Intestines ; metabolism ; microbiology ; Liver Failure, Acute ; complications ; microbiology ; Male ; Random Allocation ; Rats ; Rats, Sprague-Dawley
3.Efficacy of telbivudine in blocking the vertical transmission and the safety observation of discontinuing treatment time after delivery on mother infected with HBV.
Rong CHEN ; Shou-rong LIU ; Su-ying ZHANG ; Cheng-jing TAO
Chinese Journal of Hepatology 2012;20(9):703-704
Adult
;
Antiviral Agents
;
administration & dosage
;
adverse effects
;
therapeutic use
;
Female
;
Hepatitis B
;
prevention & control
;
transmission
;
Humans
;
Infectious Disease Transmission, Vertical
;
prevention & control
;
Mothers
;
Pregnancy
;
Pregnancy Complications, Infectious
;
drug therapy
;
virology
;
Thymidine
;
administration & dosage
;
adverse effects
;
analogs & derivatives
;
therapeutic use
;
Young Adult
4.Construction of a transfer vector based on canine adenovirus type-2.
Zhong LI ; Shou-Feng ZHANG ; Yan CUI ; Xiao-Hu WANG ; Ye LIU ; Rong-Liang HU
Chinese Journal of Biotechnology 2007;23(2):319-322
Canine adenovirus type 2 (CAV-2) has been proposed as a vector for recombinant vaccine. Alternatively, it may be an attractive tool for gene transfer due to lack of pre-existing immunity in humans. In this study, a transfer vector based on CAV-2, in which the 1381bp fragment of the E3 region was deleted, and a linker containing the Not I, Cla I, Fse I restriction enzyme sites were cloned into the deleted region. The recombinant CAV-2 genome was released from the plasmids enzyme digestion and transfected into MDCK cells by lipofectamine to obtain the recombinant virus. No significant difference in morphology, hemagglutination and replication between the recombinant and the wide type CAV-2 was found. These results indicated that this recombinant virus CAV-2-deltaE3 (NF) may be an efficient vector for gene transfer and the capacity of the vector for inserted foreign gene was up to 3.3kb.
Adenoviruses, Canine
;
genetics
;
ultrastructure
;
Animals
;
Binding Sites
;
genetics
;
Cell Line
;
Cloning, Molecular
;
DNA Restriction Enzymes
;
metabolism
;
DNA, Viral
;
chemistry
;
genetics
;
Dogs
;
virology
;
Genetic Vectors
;
genetics
;
Humans
;
Lipids
;
chemistry
;
Microscopy, Electron
;
Transfection
;
methods
;
Virus Replication
;
genetics
5.Clinical features of antiviral therapy-induced thyroid disease in patients with chronic hepatitis C.
Jun-Ping LIU ; Huan-Rong HOU ; Yi KANG ; Jia SHANG ; Yong-Ge CAO ; Shou-Qin LIANG ; Xiu JIN
Chinese Journal of Hepatology 2013;21(4):257-260
OBJECTIVETo investigate the clinical features of thyroid disease occurring in response to antiviral therapy in patients with chronic hepatitis C (CHC).
METHODSEighty-two patients diagnosed with CHC were recruited for study from our hospital between 2009 and 2010. All patients were given a 48-week course of antiviral combination therapy with pegylated-interferon (Peg-IFN; 180 mug qw ih) and ribavirin (RBV; 15 mg/kg bw). Patient sera was collected prior to treatment (baseline), at treatment weeks 24 and 48, and post-treatment week 24, and used to detect changes in levels of thyroid function markers, thyroid-specific and other autoantibodies, complement factors, and immunoglobulins (Igs). Differential expression of biomarkers was assessed between patients who developed thyroid disorder and those who did not.
RESULTSAt treatment week 48, 13.4% (11/82) of cases developed hypothyroidism, 3.7% (3/82) developed hyperthyroidism, 20.7% (17/82) tested positive for thyroglobulin antibody, and 22.0% (18/82) tested positive for thyroid peroxidase antibody. The patients who did not develop thyroid disease had significantly higher post-treatment levels (vs. baseline) of IgG (14.84 +/- 2.61 vs. 12.95 +/- 3.32 g/L, F = 10.458, P = 0.002) and C4 (0.26 +/- 0.09 vs. 0.22 +/- 0.08 g/L, F = 6.835, P = 0.011) and significantly lower IgM (0.86 +/- 0.48 vs. 1.00 +/- 0.42 g/L, F = 9.106, P = 0.003). The patients who developed thyroid disease showed no significant differences in the baseline and post-treatment levels of IgG, C4, or IgM. When the two groups of patients who did or did not develop thyroid disease were compared, there was no difference in the amount of patients who achieved sustained virological response.
CONCLUSIONAntiviral-induced thyroid disease in patients with refractory hepatitis C manifests as clinically-detectable abnormalities in serum levels of thyroid autoantibody and markers of hypothyroidism. Levels of other autoantibodies and Igs do not correlate with the development of thyroid disease in these patients, and thyroid disease does not appear to affect the efficacy of Peg-IFN + RBV antiviral therapy.
Antiviral Agents ; therapeutic use ; Drug Therapy, Combination ; Hepatitis C, Chronic ; drug therapy ; Humans ; Interferon-alpha ; therapeutic use ; Polyethylene Glycols ; therapeutic use ; Ribavirin ; therapeutic use ; Thyroid Diseases ; chemically induced
6.Application of percutaneous needle aspiration biopsy by the simulator guided to the diagnosis for pulmonary focus in coal miners' pneumoconiosis.
Si-hai LIU ; Cheng-dong QI ; Wen-shou XU ; Rui-xia ZHU ; Qin YAN ; Wen FENG ; Rong-xia SUN ; Yan-fang ZHANG ; Xiao-fu WU ; Zheng-chuan FU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2004;22(1):72-73
Aged
;
Biopsy, Needle
;
methods
;
Coal Mining
;
Humans
;
Lung
;
pathology
;
Lung Neoplasms
;
complications
;
diagnosis
;
Middle Aged
;
Pneumoconiosis
;
complications
7.Trend of incidence and mortality on thyroid cancer in China during 2003-2007
Yu-Qin LIU ; Shu-Quan ZHANG ; Wan-Qing CHEN ; Li-Li CHEN ; Si-Wei ZHANG ; Xiao-Dong ZHANG ; Rong-Shou ZHENG
Chinese Journal of Epidemiology 2012;33(10):1044-1048
Objective To analyze the trend of incidence and mortality on thyroid cancer in China.Methods Data from 32 cancer registry sites in China was collected and Jionpoint model was used to obtain the crude,age-specified incidence and mortality,both Chinese national and world age-standardized rates of incidence and mortality and their trends.Results The crude incidence of thyroid cancer was 4.44/105,and the Chinese national and world age-standardized rates were 2.89/105 and 3.31/105 respectively.The crude mortality of thyroid cancer was 0.44/105,with the Chinese national and world age-standardized rates as 0.21/105 and 0.29/105 during 2003-2007 in the country.Thyroid cancer accounted for 1.67% and 0.26% of the Chinese national and world age-standardized proportions,for total cancers.Both incidence and mortality of thyroid cancer were higher in females than in males,3.38 and 1.75 times higher in urban areas than those in rural areas.The incidence of thyroid cancer showed annually increase of 14.51% while the mortality had an increase of 1.42%.Conclusion The incidence and mortality of thyroid cancer increased rapidly in China,calling for more control efforts on this disease.
8.Efficacy comparison of two administration methods of fluconazole in the treatment of intractable vulvovaginal candidiasis
Ling WANG ; Rong LIU ; Shou-Yu WANG ; Yan CHEN ; Hui LI
Journal of Regional Anatomy and Operative Surgery 2018;27(5):364-367
Objective To discuss the efficacy comparison of two administration methods of fluconazole in the treatment of intractable vulvovaginal candidiasis( VVC) . Methods 200 patients with intractable VVC were selected in our hospital from January 2014 to January 2017;according to the random number table,all patients were divided into single-dose group and consolidation group,each with 100 cases;the single-dose group was orally administered a single dose of 150mg fluconazole,while the consolidation group was orally administered 150mg o-ral fluconazole(1 time/d, continuous treatment for 3d, and administering it 1 time after next menstruation);the clinical symptom remission time,curative effect,adverse reaction and recurrence were compared in two groups. Results The vaginal itching,abdomen pain,vaginal se-cretion,mucosal hyperemia,edema remission time and the treatment efficiency rate,adverse reaction rate of single group and consolidation group were basically the same;and the difference was not statistically significant (P>0. 05). During the 12-month follow-up,the recurrence rate of consolidated group was significantly lower than that of single-dose group,the difference was statistically significant(P<0. 05). Con-clusion Compared with the single dose,the fluconazole consolidation therapy also has the good therapeutic efficacy and safety in the treat-ment of intractable VVC,and it can effectively reduce the recurrence of patients,so it is worth further clinical promotion.
9.Clinical progress on moxibustion in preventing and treating adverse effects of surgery or chemoradiotherapy for breast cancer
Bing-Rong LI ; Yin SHOU ; Bi-Meng ZHANG ; Peng LIU ; Long YUAN ; Si-Wei XU ; Yang YANG ; Kai-Yong ZHANG ; Hui-Ru JIANG ; Yi-Fan JIA
Journal of Acupuncture and Tuina Science 2018;16(2):120-126
Breast cancer has the highest incidence rate among all women's malignant tumors worldwide.Surgery,radiotherapy and chemotherapy are three major treatments,while most patients showed adverse effects or complications during or after the treatment,including lymphedema,gastrointestinal reactions and leukopenia,which cause severe impact on patients' recovery and quality of life.Moxibustion has been used and certified to alleviate adverse effects of surgery or chemoradiotherapy for breast cancer.We have summarized literatures in recent years and suggest more systematic research in the future for the underlying mechanism.
10.Effect of prostaglandin E1 on the expression of tissue inhibitor of metalloproteinase-1 in experimental liver fibrosis rats.
Shao-jun LIU ; Shou-rong SHEN ; Xiao-yan WANG ; Wu-liang TANG ; Fen WANG
Journal of Central South University(Medical Sciences) 2006;31(3):383-386
OBJECTIVE:
To investigate the effect of prostaglandin E1 (PGE1) on the expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in experimental liver fibrosis rats.
METHODS:
The liver fibrosis model was established by carbon tetrachloride. Rats were divided into a control group and PGE1-treated group. The pathological changes of the liver tissue from the two groups, the semi-quantitative analysis of hepatitic activity in HE stain sections, the pathological image quantitative analysis of the fibrosis degree, TIMP-1 positive cells, and the content of collagen were synthetically analysed.
RESULTS:
The mark changes of liver pathology in HE stain sections were that the degree of hepatitic activity in the PGE1-treated group was obviously lower than that in the control group (P < 0.05). The fibrosis degree, TIMP-1 positive cells and the collagenous fibers decreased in the PGE1-treated group (P <0.05).
CONCLUSION
PGE1 has an anti-hepatofibrosis effect in the experimental rats, the inflammation of liver is light, and the proliferation of collagenous fibers can be restrained, whose mechanism is probably associated with the suppression of TIMP-1 expression caused by PGE1.
Alprostadil
;
pharmacology
;
Animals
;
Carbon Tetrachloride
;
Carbon Tetrachloride Poisoning
;
Female
;
Liver Cirrhosis, Experimental
;
chemically induced
;
metabolism
;
Male
;
Random Allocation
;
Rats
;
Rats, Wistar
;
Tissue Inhibitor of Metalloproteinase-1
;
biosynthesis
;
genetics